These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22444788)

  • 1. An assessment of the association between carvedilol exposure and severe hypersensitivity reactions, angioedema, and anaphylactic reactions: a retrospective nested case-control analysis.
    Koro CE; Sowell MD; Stender M
    Clin Ther; 2012 Apr; 34(4):870-7. PubMed ID: 22444788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
    Fonseca V; Sharma PP; Shah M; Deedwania P
    Curr Med Res Opin; 2011 Apr; 27(4):799-807. PubMed ID: 21306286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.
    Lang DM; Alpern MB; Visintainer PF; Smith ST
    Arch Intern Med; 1993 Sep; 153(17):2033-40. PubMed ID: 8102844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study.
    Opasich C; Boccanelli A; Cafiero M; Cirrincione V; Sindaco DD; Lenarda AD; Luzio SD; Faggiano P; Frigerio M; Lucci D; Porcu M; Pulignano G; Scherillo M; Tavazzi L; Maggioni AP;
    Eur J Heart Fail; 2006 Oct; 8(6):649-57. PubMed ID: 16466962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.
    Krum H; Mohacsi P; Katus HA; Tendera M; Rouleau JL; Fowler MB; Coats AJ; Roecker EB; Packer M;
    Am Heart J; 2006 Jan; 151(1):55-61. PubMed ID: 16368292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peyronie disease in association with carvedilol: a case report.
    Bell DS
    South Med J; 2008 Nov; 101(11):1157-8. PubMed ID: 19088529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible adverse skin reaction to carvedilol.
    Simpson SH; Tsuyuki RT; Gutierrez R; Lo A; Teo KK
    Can J Cardiol; 1998 Oct; 14(10):1277-9. PubMed ID: 9852941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of carvedilol on survival in severe chronic heart failure.
    Packer M; Coats AJ; Fowler MB; Katus HA; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Roecker EB; Schultz MK; DeMets DL;
    N Engl J Med; 2001 May; 344(22):1651-8. PubMed ID: 11386263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study.
    Krum H; Hill J; Fruhwald F; Sharpe C; Abraham G; Zhu JR; Poy C; Kragten JA
    Eur J Heart Fail; 2006 May; 8(3):302-7. PubMed ID: 16198627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
    Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
    Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
    Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
    Signorovitch JE; Samuelson TM; Ramakrishnan K; Marynchenko M; Wu EQ; Blum SI; Ramasamy A; Chen S
    Curr Med Res Opin; 2012 Apr; 28(4):591-9. PubMed ID: 22352883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
    Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
    Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of carvedilol on the serum lipid profile.
    Sharp RP; Sirajuddin R; Sharief IM
    Ann Pharmacother; 2008 Apr; 42(4):564-71. PubMed ID: 18364407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.